Lora T. Mcglade - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Lora T. Mcglade's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Lora T. Mcglade

Lora T. Mcglade

Verified

Senior Editor, Pediatric News

Final Covers

Agriculture, Gender and inequality real estate, HealthFinance, Climate change Factcheck, Power sector works and infrastructure

Doesn’t Cover

Not in a vaunted position to be so picky just yet.

Journalist Type

-

Seniority Positions

Industries

Medium Formats

-

Content

Total articles 40

  • Rethink Fall Risk Assessment When Choosing Between Gabapentin and Duloxetine for Older Adults

    By Lora T. Mcglade Verified| MDEdge Verified TOPLINE:Among 57,086 older adults, new gabapentin users demonstrated lower fall-related healthcare visits than duloxetine users, with a weighted cumulative incidence of 84.44 vs 158.21 per 1000 person-years at 180 days. Incident gabapentin use showed a 48% lower hazard of falls at 6-month follow-up, with no increase in severe fall-related events.  METHODOLOGY:Researchers conducted a new user, active comparator cohort study using IBM MarketScan Research Databases from January 2014 to December 2021.

    By Lora T. Mcglade Verified · MDEdge

    Jan. 08, 2025

  • Untreated Infertility Linked to Higher Risk for Systemic Autoimmune Rheumatic Disease After Childbirth

    By Lora T. Mcglade Verified| MDEdge Verified TOPLINE:The association persists even after accounting for adverse pregnancy outcomes. Women who have experienced infertility without fertility treatment show a 25% higher risk for systemic autoimmune rheumatic disease (SARD) up to 9 years after delivery, compared with those without infertility. METHODOLOGY:Population-based cohort study analyzed 568,053 singleton births among 465,078 women aged 18-50 years without pre-existing SARD in Ontario, Canada, from 2012 to 2021.

    By Lora T. Mcglade Verified · MDEdge

    Dec. 10, 2024

  • When Is the Best Time to Deliver for Pregnant Patients With Chronic Hypertension?

    By Lora T. Mcglade Verified| MDEdge Verified TOPLINE:Among pregnant patients with chronic hypertension, delivery at 39 weeks of gestation provides an optimal balance between stillbirth risk and neonatal outcomes. Analysis of 227,977 term singleton deliveries shows consistent findings across different patient subgroups. METHODOLOGY:A population-based retrospective cohort study analyzed 227,977 nonanomalous singleton term births in the United States from 2014 to 2018 among patients with chronic hypertension.

    By Lora T. Mcglade Verified · MDEdge

    Dec. 10, 2024

As seen in

Company Info

Pediatric News

Parsippany-Troy Hills, New Jersey, United States

+1 240-221-2468